Mepolizumab, an IL-5 inhibitor, failed to alleviate moderate persistent asthma symptoms in a phase II trial of patients resistant to corticosteroids. References and Resources Flood-Page P, Swenson C,…
Douglas P. Slakey, MD, MPH, Regents Professor and Chair, Department of Surgery, Tulane University School of Medicine, discusses optimizing transplant patient outcomes. References and Resources American Liver Foundation…